Table 1 Demographic and baseline characteristics
Variables | Mean ± SD/number (%) |
|---|---|
Age (years) | 54.10 ± 9.06 |
BMI | 29.3 ± 4.5 |
Sex (M:F) | 5:15 |
Disease duration (years) | 11.53 ± 10.22 (median: 6, IQR: 12) |
CRP (mg/l) | |
 ○Normal | 15 (75%) |
 ○High | 2 (10%) |
Employment | |
 ○Yes | 47.6% |
 ○No | 52.4% |
History of foot and ankle injury | |
 ○Yes | 57% |
 ○No | 43% |
DMARDs | 5 (25%) |
Biological | 6 (30%) |
DMARDs and biological | 7 (35%) |
DMARD and/or biological therapy | 18 (90%) |
Change in medication during the study | 2 (10%) |
Foot type | |
 ○Normal foot | 5 (25%) |
 ○Pes cavus | 8 (40%) |
 ○Pes planus | 7 (35%) |
Deformities | |
 ○Rearfoot valgus | 13 (65%) |
 ○Hallux valgus | 5 (25%) |
 ○Hallux rigidus | 5 (25%) |
 ○Hammer toes | 14 (70%) |
Pain site | |
 ○Toes | 16 (80%) |
 ○Metatarsus | 16 (80%) |
 ○Heel | 11 (55%) |
 ○Ankle | 17 (85%) |